Financials
- Market Capitalization 23.19 M
- Employee 12
- Founded 2011
- CEO N/A
- Website www.skyebioscience.com
- Headquarter Nevada, United States
- FIGI BBG00433GZN1
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.53
Fiyat/satışlar oranı
82.43
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 4549 | MRKR Marker Therapeutics, Inc. - Common Stock | 1.46 USD | -3.31% | -5.19% | +5.80% | -9.88% | 24.34 M USD | ||
| 4559 | NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 0.73 USD | 0.00% | +5.80% | -2.67% | -63.50% | 23.77 M USD | ||
| 4590 | ALGS Aligos Therapeutics, Inc. - Common stock | 6.36 USD | -3.93% | +7.61% | +20.00% | -35.04% | 22.03 M USD | ||
| 4591 | VYNE VYNE Therapeutics Inc. - Common Stock | 0.66 USD | +3.13% | 0.00% | +1.54% | -50.00% | 22.01 M USD |